$NEOS saw a sell-off on Friday?

Neos Therapeutics (NEOS) saw a sell-off on Friday despite getting approval for its Adzenys ER treatment for ADHD that same day.

Read our take on the news, in our Daily Pharma Scoop at SeekingAlpha Marketplace.